Zobrazeno 1 - 2
of 2
pro vyhledávání: ''
Autor:
Ahmad Awada, A. Douglas Laird, Geoffrey I. Shapiro, Patrick Schöffski, Sara M. Tolaney, Hovav Nechushtan, Chris A. Yasenchak, Eric P. Winer, Bridget O’Keeffe, I. G. Ron
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 160 (2
Breast cancer research and treatment, 160 (2
Purpose: Cabozantinib (XL184), a multi-targeted oral tyrosine kinase inhibitor with activity against MET, VEGFR2, AXL, and other tyrosine kinases, was assessed in a cohort of metastatic breast cancer (MBC) patients in a phase II randomized discontinu
Autor:
Ingeborg J. H. Vriens, Marc B. I. Lobbes, Annelotte C. M. van Bommel, Marjolein L. Smidt, Thijs van Dalen, Grard A. P. Nieuwenhuijzen, Henk Struikmans, Carolien H. Smorenburg, Adri C. Voogd, Liesbeth J. Boersma, Vivianne C. G. Tjan-Heijnen, Sabine Siesling
Publikováno v:
Breast cancer research and treatment, 162(2), 353-364. Springer
Breast Cancer Research and Treatment, 162(2), 353-364. Springer, Cham
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 162(2), 353-364. Springer, Cham
Breast Cancer Research and Treatment
Purpose In this retrospective population-based cohort study, we analyzed breast MRI use and its impact on type of surgery, surgical margin involvement, and the diagnosis of contralateral breast cancer. Methods All Dutch patients with cT1–4N0–3M0